Dutton adds new medicines to Pharmaceutical Benefits Scheme

SUFFERERS of cystic fibrosis and a rare disease that attacks organ function will be able to access cheaper treatments from December.

Health Minister Peter Dutton today announced two new medicines for the diseases would be listed on the Pharmaceutical Benefits Scheme.

The medicines, Kalydeco, for cystic fibrosis and Soliris, or atypical haemolytic uraemic syndrome, will be listed from December 1.

Mr Dutton said listing the Kalydeco medicine would help more than 250 Australians affected by cystic fibrosis, saving about $300,000 a year for each patient.

He also said listing the Soliris medicine, for the ultra-rare aHUS condition, would help sufferers and their families meet the $500,000 annual cost of that medicine.

Listing both medicines on the PBS will cost the government about $238 million over the next four years, the drug manufacturers will have to meet some conditions prior to the listing.
- APN NEWSDESK
 


VIDEO: Up to 20 shots fired in village, police took cover

Premium Content VIDEO: Up to 20 shots fired in village, police took cover

Police said officers, locals came very close to getting hurt

GALLERY, VIDEO: Aftermath of the Dunoon shooting

Premium Content GALLERY, VIDEO: Aftermath of the Dunoon shooting

A man will face court charged over an alleged public place shooting

Man wanted on an outstanding warrant

Premium Content Man wanted on an outstanding warrant

He is believed to frequent Ballina, Lismore, Tuckombil and Nimbin